Verein für Krebsforschung

Verein für Krebsforschung (Association for Cancer Research) is a Swiss non-profit organization founded in 1935, specializing in integrative oncology and anthroposophic medicine. The association is the developer of Iscador, the world's first and most widely used mistletoe-based cancer therapy. Through its research arm, the Hiscia Institute, the organization conducts pharmaceutical development, botanical research, and clinical studies on Viscum album extracts. Its work focuses on the immunomodulatory and cytotoxic properties of mistletoe lectins and viscotoxins to support cancer patients. Headquartered in Arlesheim, Switzerland, the association bridges the gap between traditional pharmaceutical manufacturing and complementary medical practices.